Sign in

CIK 0001018735 · Accelerated filer

NYMOX PHARMACEUTICAL CORP

Sign in to watch
Ticker
NYMXF
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Entity type
other
Phone
1-800-936-9669
Business address
9900 CAVENDISH BLVD., SUITE 306, ST. LAURENT, QUEBEC CANADA, Quebec, Canada, H4M 2V2
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-10-29 Averback Paul CEO Sale −1,687,600 $2.50 $4.2M 21,643,948
2018-10-26 Averback Paul CEO Sale −100,000 $1.75 $175K 23,331,448

Page 1 of 1 · 2 trades